Companies Enfusion
Enfusion (ENFN): executive pay, fiscal 2023
Free brief. Every figure links to the company’s own filing.
Enfusion no longer files a proxy statement; its last pay data is FY2023.
CEO pay, last three years
- $1,657,048FY2022
- $1,455,190FY2023
CEO total pay was $1,455,190 in fiscal 2023, down from $1,657,048 in fiscal 2022.
FY2023: salary $650,025 · stock awards $370,401 · option awards $250,000
Executives and directors
Bradley Herring · CFONeal Pawar · COOOleg Movchan · CEOBradford E. Bernstein · Independent DirectorDeirdre Somers · Independent DirectorJan R. Hauser · Independent DirectorKathleen Traynor DeRose · Independent DirectorLawrence Leibowitz · Independent DirectorMichael Spellacy · Chair of the BoardRoy Luo · Independent Director
Frequently asked questions
Who was the highest-paid executive at Enfusion in fiscal 2023?
As disclosed, Neal Pawar (Chief Operating Officer) was the highest-paid executive at Enfusion in fiscal 2023, with total compensation of $2,616,626.
How much does Enfusion spend in total on board compensation for fiscal 2023?
As disclosed, Enfusion reported total board compensation of $1,812,090 for fiscal 2023.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Neal Pawar | $44,320 | $0 | $2,570,306 | $0 | $0 | $0 | $0 | $2,616,626 |
| Chief Operating Officer | ||||||||
| Oleg Movchan | 650,025 | — | 370,401 | 250,000 | 180,600 | — | 4,164 | 1,455,190 |
| Chief Executive Officer and Director | ||||||||
| Bradley Herring | 450,017 | — | 532,773 | — | 124,100 | — | — | 1,106,890 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Neal Pawar | $2,616,626 | — | — | — |
| Oleg Movchan | 1,455,190 | 1,657,048 | — | ↓ −201,858 |
| Bradley Herring | 1,106,890 | 1,793,045 | — | ↓ −686,155 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company targets a general competitive position based on independent third-party benchmark analytics to inform the mix of base salary, annual bonus opportunity, and long-term incentive opportunities. The Board believes that awards tying to the appreciation in value of the Company provide executives with a strong link to long-term performance, create an ownership culture, and help align the interests of executive officers and equity holders.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Meridian Compensation Partners |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2023
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Bradley Herring | OTHER | — | — | — | — | — | $532,773 |
| Oleg Movchan | OTHER | — | — | — | — | — | 370,401 |
| Neal Pawar | OTHER | — | — | — | — | — | 2,570,306 |
Vehicle mix — grant-date fair value by award type
Grant-level vehicle detail not disclosed.
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2023
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Oleg Movchan | PSU | 22,604 | — | $219,259 |
| Bradley Herring | PSU | 40,688 | — | 394,674 |
| Bradley Herring | PSU | 175,000 | — | 1,697,500 |
| Oleg Movchan | PSU | 250,000 | — | 2,425,000 |
| Neal Pawar | PSU | 425,000 | — | 4,122,500 |
| Neal Pawar | PSU | 580,000 | — | 5,626,000 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Michael SpellacyIndependent · Board Chair | $185,914 | $472,290 | — | — | — | $658,204 |
| Deirdre SomersIndependent · Nominating and Corporate Governance · Audit | 50,329 | 412,542 | — | — | — | 462,871 |
| Jan R. HauserIndependent · Audit (Chair) · Compensation | 66,499 | 168,172 | — | — | — | 234,671 |
| Kathleen Traynor DeRoseIndependent · Compensation (Chair) · Nominating and Corporate Governance | 60,000 | 168,172 | — | — | — | 228,172 |
| Lawrence LeibowitzIndependent · Nominating and Corporate Governance (Chair) · Audit | 60,000 | 168,172 | — | — | — | 228,172 |
| Roy LuoIndependent · Compensation · Nominating and Corporate Governance | 0 | 0 | — | — | — | 0 |
| Bradford E. BernsteinIndependent · Compensation | 0 | 0 | — | — | — | 0 |
| Oleg MovchanEmployee director | — | — | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $125,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $422,742 |
| Equity awards (grant-date value) | $1,389,348 |
| All other compensation | $0 |
| Total cost of the board | $1,812,090 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Enfusion as a peer
Companies that benchmark against ENFN
10 companies name ENFN as a compensation peer
The list of companies that name ENFN as a peer is temporarily unavailable — recheck shortly.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Enfusion | 2023 | Oleg Movchan | $650,025 | $370,401 | $250,000 | $180,600 | $1,455,190 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2023 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Bronwen Bastone | Chief People Officer | 2025-01-07 | D | 809 | $10 | $8,195 | Common | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-01-07 | D | 976 | 10 | 9,887 | Common | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-01-07 | D | 4,134 | 10 | 41,877 | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-01-07 | D | 2,771 | 10 | 28,070 | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-01-07 | D | 796 | 10 | 8,063 | Common | Form 4 ↗ |
| Deirdre Somers | Director | 2025-01-13 | D | 1,637 | 11 | 17,238 | Common | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-02-26 | A | 58,202 | 0 | 0 | RSU | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-02-26 | A | 6,296 | 0 | 0 | Common | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-02-26 | A | 3,434 | 0 | 0 | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-02-26 | A | 9,157 | 0 | 0 | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-02-26 | A | 13,228 | 0 | 0 | RSU | Form 4 ↗ |
| Oleg Movchan | Director | 2025-02-26 | A | 110,230 | 0 | 0 | RSU | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-02-26 | A | 6,868 | 0 | 0 | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-02-26 | A | 2,125 | 0 | 0 | Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-02-26 | A | 5,724 | 0 | 0 | Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-02-26 | A | 26,456 | 0 | 0 | RSU | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-02-26 | A | 17,637 | 0 | 0 | RSU | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-02-26 | A | 110,230 | 0 | 0 | RSU | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-02-28 | D | 540 | 11 | 6,167 | Common | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-03-03 | D | 1,081 | 11 | 12,411 | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-03-03 | D | 2,790 | 11 | 32,032 | Common | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-03-03 | D | 2,769 | 11 | 31,791 | Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-03-03 | D | 2,064 | 11 | 23,697 | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-03-03 | D | 219 | 11 | 2,514 | Common | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-03-03 | D | 1,533 | 11 | 17,600 | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-03-04 | D | 1,233 | 11 | 14,013 | Common | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-03-05 | D | 4,645 | 11 | 52,837 | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-03-05 | D | 542 | 11 | 6,165 | Common | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-03-05 | D | 14,560 | 11 | 165,620 | Common | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-03-05 | D | 1,695 | 11 | 19,281 | Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-03-05 | D | 3,126 | 11 | 35,558 | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-03-06 | D | 11,452 | 11 | 130,473 | Common | Form 4 ↗ |
| Bradford E. Bernstein | Director | 2025-04-21 | D | 32,440,463 | — | — | Common, indirect | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-04-21 | D | 10,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-04-21 | D | 35,294 | — | — | Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-04-21 | D | 161,893 | — | — | Common | Form 4 ↗ |
| Bronwen Bastone | Chief People Officer | 2025-04-21 | D | 15,864 | — | — | Common | Form 4 ↗ |
| Michael Spellacy | Director | 2025-04-21 | D | 56,810 | — | — | Common | Form 4 ↗ |
| Kathleen Traynor DeRose | Director | 2025-04-21 | D | 60,716 | — | — | Common | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-04-21 | D | 45,799 | — | — | Common | Form 4 ↗ |
| Matthew Campobasso | General Counsel | 2025-04-21 | D | 25,147 | — | — | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-04-21 | D | 31,303 | — | — | Common | Form 4 ↗ |
| Valeria Gutowski | Chief Accounting Officer | 2025-04-21 | D | 16,319 | — | — | Common | Form 4 ↗ |
| Lawrence Leibowitz | Director | 2025-04-21 | D | 175,572 | — | — | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-04-21 | D | 100,000 | — | — | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-04-21 | D | 250,000 | — | — | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-04-21 | D | 230,039 | — | — | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-04-21 | D | 51,808 | — | — | Common | Form 4 ↗ |
| Oleg Movchan | Director | 2025-04-21 | D | 1,151,818 | — | — | Common, indirect | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-04-21 | D | 216,357 | — | — | Common | Form 4 ↗ |
| Bradley Herring | Chief Financial Officer | 2025-04-21 | D | 108,332 | — | — | Common | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-04-21 | D | 580,000 | — | — | Common | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-04-21 | D | 501,695 | — | — | Common | Form 4 ↗ |
| Neal Pawar | Chief Operating Officer | 2025-04-21 | D | 135,613 | — | — | Common | Form 4 ↗ |
| Roy Luo | Director | 2025-04-21 | D | 5,030,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Roy Luo | Director | 2025-04-21 | D | 538,887 | — | — | Common, indirect | Form 4 ↗ |
| ICONIQ Strategic Partners V, L.P. | Greater-than-10% holder | 2025-04-21 | D | 5,030,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| ICONIQ Strategic Partners V, L.P. | Greater-than-10% holder | 2025-04-21 | D | 7,748,000 | — | — | Common, indirect | Form 4 ↗ |
| Roy Luo | Director | 2025-04-21 | D | 722,707 | — | — | Common, indirect | Form 4 ↗ |
| Deirdre Somers | Director | 2025-04-21 | D | 41,675 | — | — | Common | Form 4 ↗ |
| Roy Luo | Director | 2025-04-21 | D | 7,748,000 | — | — | Common, indirect | Form 4 ↗ |
| Jan R. Hauser | Director | 2025-04-21 | D | 57,925 | — | — | Common | Form 4 ↗ |
| ICONIQ Strategic Partners V, L.P. | Greater-than-10% holder | 2025-04-21 | D | 722,707 | — | — | Common, indirect | Form 4 ↗ |
| ICONIQ Strategic Partners V, L.P. | Greater-than-10% holder | 2025-04-21 | D | 538,887 | — | — | Common, indirect | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (81 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Neal Pawar. DEF 14A, filed 2024-04-26. Section “Executive Compensation”. As printed: 2,616,626. View filing ↗
- Section 01, Oleg Movchan. DEF 14A, filed 2024-04-26. Section “Executive Compensation”. As printed: 1,455,190. View filing ↗
- Section 01, Bradley Herring. DEF 14A, filed 2024-04-26. Section “Executive Compensation”. As printed: 1,106,890. View filing ↗
- Section 03, Bradley Herring OTHER. DEF 14A, filed 2024-04-26. Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. View filing ↗
- Section 03, Oleg Movchan OTHER. DEF 14A, filed 2024-04-26. Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. View filing ↗
- Section 03, Neal Pawar OTHER. DEF 14A, filed 2024-04-26. Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. View filing ↗
- Section 08, Michael Spellacy. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 658,204. View filing ↗
- Section 08, Deirdre Somers. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 462,871. View filing ↗
- Section 08, Jan R. Hauser. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 234,671. View filing ↗
- Section 08, Kathleen Traynor DeRose. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 228,172. View filing ↗
- Section 08, Lawrence Leibowitz. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 228,172. View filing ↗
- Section 08, Roy Luo. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Bradford E. Bernstein. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Oleg Movchan. DEF 14A, filed 2024-04-26. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Bronwen Bastone 2025-01-07. Form 4, filed 2025-01-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-01-07. Form 4, filed 2025-01-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-01-07. Form 4, filed 2025-01-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-01-07. Form 4, filed 2025-01-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-01-07. Form 4, filed 2025-01-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deirdre Somers 2025-01-13. Form 4, filed 2025-01-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-02-26. Form 4, filed 2025-02-28. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-02-28. Form 4, filed 2025-03-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-03-04. Form 4, filed 2025-03-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-03-05. Form 4, filed 2025-03-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-03-05. Form 4, filed 2025-03-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-03-05. Form 4, filed 2025-03-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-03-05. Form 4, filed 2025-03-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-03-05. Form 4, filed 2025-03-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-03-06. Form 4, filed 2025-03-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradford E. Bernstein 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bronwen Bastone 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Spellacy 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kathleen Traynor DeRose 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Campobasso 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Valeria Gutowski 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Lawrence Leibowitz 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Oleg Movchan 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bradley Herring 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neal Pawar 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Roy Luo 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Roy Luo 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, ICONIQ Strategic Partners V, L.P. 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, ICONIQ Strategic Partners V, L.P. 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Roy Luo 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deirdre Somers 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Roy Luo 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jan R. Hauser 2025-04-21. Form 4, filed 2025-04-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, ICONIQ Strategic Partners V, L.P. 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, ICONIQ Strategic Partners V, L.P. 2025-04-21. Form 4, filed 2025-04-23. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 422,742 + equity 1,389,348 + all other 0 = 1,812,090, summed across the director compensation table rows.
- Enfusion (subject), Section 10b CEO total. DEF 14A, filed 2024-04-26. CEO total compensation as printed in Enfusion's own proxy. As printed: 1,455,190. View filing ↗